Compound information
- Natural Products
- NACP111136
- Molecular Formula
- C19H26O4
- Molecular Weight
- 318.183109312 g/mol
- Structure
-
- IUPAC Name
- 1-(4-hydroxy-3-methoxy-phenyl)dodec-1-ene-3,5-dione
- InChI
- InChI=1S/C19H26O4/c1-3-4-5-6-7-8-16(20)14-17(21)11-9-15-10-12-18(22)19(13-15)23-2/h9-13,22H,3-8,14H2,1-2H3
- InChI Key
- QOJHXMDTWFYFRL-UHFFFAOYSA-N
- SMILES
- O=C(C=CC1=CC=C(O)C(OC)=C1)CC(=O)CCCCCCC
- CAS
- 748159-34-4
- SuperClass
- Phenylpropanoids and polyketides
- Class
- Cinnamic acids and derivatives
- SubClass
- Hydroxycinnamic acids and derivatives
- Source
- CNP0225063
Warheads
- Carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 23 | Ring Count | 1 |
Heteroatom Count | 4 | Rotatable Bond Count | 11 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 63.6 Å2 | LogP | 3.888 |
LogS | -5.396 | LogD | 3.275 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.838 | Pgp substrate | 0.002 |
HIA | 0.967 | F20 % | 0.606 |
F30 % | 0.243 | Caco-2 | -4.738 |
MDCK | -4.577 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.997 | PPB | 43.099 |
VD | 0.926 | Fu | 1.068 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.889 | CYP1A2 substrate | 0.569 |
CYP2A6 substrate | 0.445 | CYP2B6 substrate | 0.63 |
CYP2C19 inhibitor | 0.254 | CYP2C19 substrate | 0.692 |
CYP2C8 substrate | 0.66 | CYP2C9 inhibitor | 0.533 |
CYP2C9 substrate | 0.024 | CYP2D6 inhibitor | 0.021 |
CYP2D6 substrate | 0.165 | CYP2E1 substrate | 0.302 |
CYP3A4 inhibitor | 0.258 | CYP3A4 substrate | 0.074 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.951 | CL | 10.854 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.272 | Hepatotoxicity | 0.22 |
Mutagenicity | 0.358 | Rat Oral Acute Toxicity | 0.285 |
FDAMDD | 0.412 | Skin Sensitization | 0.996 |
Carcinogenicity | 0.107 | Eye Corrosion | 0.005 |
Eye Irritation | 0.926 | Respiratory Toxicity | 0.861 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.641 | IGC50 | 5.577 |
LC50FM | 6.116 | LC50DM | 5.149 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.395 | NR-AR-LBD | 0.616 |
NR-AhR | 0.219 | NR-Aromatase | 0.285 |
NR-ER | 0.682 | NR-ER-LBD | 0.416 |
NR-PPAR-gamma | 0.868 | SR-ARE | 0.228 |
SR-ATAD5 | 0.698 | SR-HSE | 0.75 |
SR-MMP | 0.851 | SR-p53 | 0.527 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.